Early-stage drug discovery requires a clear understanding of how candidate compounds impact cellular function before advancing to expensive downstream studies. Relying on a single biomarker often ...
SAN DIEGO--(BUSINESS WIRE)--Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has launched the next generation of its multi-omics and real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results